Patents by Inventor Kevin L. Knudtson

Kevin L. Knudtson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5821059
    Abstract: A system for identifying mycoplasma regulatory sequences with protein fusion constructs has been developed. This system has identified mycoplasma regulatory sequences that can be used in expression vectors. The expression vectors employing these mycoplasma regulatory sequences permit the expression of foreign DNA sequences in mycoplasma hosts, such as Acholeplasma.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: October 13, 1998
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: F. Chris Minion, Kevin L. Knudtson
  • Patent number: 5795974
    Abstract: The gene encoding the superantigen Mycoplasma arthritidis T-cell mitogen (MAM) was molecularly cloned. The mam gene was modified by site-directed mutagenesis to change UGA codons, which in mycoplasmas are read as tryptophan codons instead of universal stop codons, to UGG codons such that the gene could be expressed in standard expression systems. Recombinant MAM, including extra amino acid residues at the N- and C-termini, were expressed and discovered to be biologically active. Certain amino acid substitutions in active regions of the protein also yield biologically active MAM proteins. A method of diagnosing rheumatoid arthritis using recombinant MAM protein in an ELISA assay is disclosed.
    Type: Grant
    Filed: March 22, 1996
    Date of Patent: August 18, 1998
    Assignee: University of Utah Research Foundation
    Inventors: Barry C. Cole, Curtis L. Atkin, Kevin L. Knudtson